Research ArticleTUMOR IMMUNOLOGY

A tumor-specific mechanism of Treg enrichment mediated by the integrin αvβ8

See allHide authors and affiliations

Science Immunology  26 Mar 2021:
Vol. 6, Issue 57, eabf0558
DOI: 10.1126/sciimmunol.abf0558

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Enriching your intratumoral Tregs

Regulatory T cells (Tregs) are immunosuppressive and enriched in the tumor microenvironment (TME), which subsequently leads to the promotion of tumor growth. The mechanism behind Treg enrichment in the TME is not known. Here, Seed et al. demonstrated that integrin αvβ8 expression on tumor cells induced Treg differentiation intratumorally by binding to latent TGF-β on T cells, leading to TGF-β activation. Antibody blockade of αvβ8 depleted intratumoral Tregs and delayed tumor growth in murine tumor models. However, targeting of TGF-β with small-molecule inhibitors to block Treg formation was ineffective, as modeling of αvβ8/latent TGF-β interactions showed limited access to TGF-β. Thus, these data suggest that targeting αvβ8 expression on tumors with antibodies can inhibit Treg formation and subsequent tumor growth, providing a potential therapeutic option for cancer patients.

View Full Text

Stay Connected to Science Immunology